A paper entitled “Clinical effects of the enhanced external counterpulsation therapy in patients with ischemic chronic heart failure exacerbation COVID-19” has just been published in the European Heart Journal on 14 October 2021. The authors I Shashenkov, S.A. Gabrushenko, S.L. Babak and A.G. Mallavin have many years of experience with EECP therapy in Russia and have published on EECP therapy before. In this paper they concluded that “Enhanced external counterpulsation (EECP) therapy sustainably improves NYHA functional class and LVEF in patients with ischemic CHF exacerbation after COVID-19”. For more information go to https;//doi.org/10.1093/eurheartj/ehab724.0928.
Recent News
Recently Published Case Study Explores the Possibility of Using EECP Therapy to Treat Long – COVID POTS
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Join the IEECPS!
The IEECPS gives you the opportunity to make a contribution and be part of a world wide effort to improve the utilization of EECP Therapy to slow down or prevent the progression of cardiovascular disease.